This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday – Johnson & Johnson (NYSE:JNJ)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Goldman Sachs analyst David Roman initiated coverage on HealthEquity, Inc. HQY with a Neutral rating and announced a price target of $108. HealthEquity shares closed at $95.70 on Thursday. See how other analysts view this stock.
• Wolfe Research analyst Alexandria Hammond initiated coverage on Pfizer Inc. PFE with an Underperform rating and announced a price target of $25. Pfizer shares closed at $26.02 on Thursday. See how other analysts view this stock.
• Stifel analyst Brian Brophy initiated coverage on EMCOR Group, Inc. EME with a Buy rating and announced a price target of $600. EMCOR shares closed at $498.11 on Thursday. See how other analysts view this stock.
• Redburn Atlantic analyst Harry Read initiated coverage on Insight Enterprises, Inc. NSIT with a Buy rating and announced a price target of $220. Insight Enterprises shares closed at $152.63 on Thursday. See how other analysts view this stock.
• Wolfe Research analyst Alexandria Hammond initiated coverage on Johnson & Johnson JNJ with an Outperform rating and announced a price target of $190. Johnson & Johnson shares closed at $151.87 on Thursday. See how other analysts view this stock.

Considering buying JNJ stock? Here’s what analysts think:

Read More:

• Dow Dips Over 200 Points Following Economic Reports, Tesla Tumbles On Potential Removal Of EV Tax Credit: Fear Index Remains In ‘Greed’ Zone